GE HealthCare Technologies (GEHC) Stock Price & Analysis

GEHC$83.02+1.18 +1.44%
Medical - DevicesLarge Cap
Compare
Market cap$37.54BEnterprise value$46.35BRevenue (TTM)$20.61BMarket positionTop 25%

Score

35
Bearish
Value
36
Quality
42
Growth
28

AI Analysis

Snapshot

GE HealthCare Technologies doesn’t screen as a clean setup today — Stocklytics 35/100 leaves more to prove. Under the hood: P/E 22.2, rich vs its own history, plus revenue compounding ~4% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

36
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

28
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

42
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

GE HealthCare Technologies Inc. (GEHC) last printed $83.02. Equity value is $37.54B. Trailing earnings multiple 21.33. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2019202020212022202320242025
$16.63B$17.16B$17.59B$18.34B$19.55B$19.67B$20.62B

About

GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.

GE HealthCare Technologies (GEHC) Stock Price & Analysis

GEHC price $83.02 +1.18 +1.44%

Ticker
GEHC
Price
$83.02
Change
+1.18 +1.44%
Market cap
$37.54B
P/E
21.33
Forward P/E
15.50
Dividend yield
0.17%
Beta
0.77
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
35
Value
36
Quality
42
Growth
28

Stocklytics score rationale: value 36, quality 42, growth 28.

AI Score 75. GE HealthCare Technologies Inc. has a market cap of approximately $38.8 billion and a price of $85.81, indicating a solid market presence

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener